Travere Therapeutics
TVTX
TVTX
217 hedge funds and large institutions have $1.77B invested in Travere Therapeutics in 2025 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 87 increasing their positions, 56 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
11% more funds holding
Funds holding: 196 → 217 (+21)
7% more capital invested
Capital invested by funds: $1.66B → $1.77B (+$116M)
0.28% less ownership
Funds ownership: 110.72% → 110.44% (-0.28%)
Holders
217
Holding in Top 10
4
Calls
$29.5M
Puts
$11.4M
Top Buyers
| 1 | +$68.3M | |
| 2 | +$32.4M | |
| 3 | +$27.1M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$15.6M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$13.4M |
Top Sellers
| 1 | -$36.8M | |
| 2 | -$31M | |
| 3 | -$23.5M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$19M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$17.4M |
